Advertisement

Index by author

February 01, 1989; Volume 248,Issue 2

A

  1. Aamodt, R

    1. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;

  2. Abrahams, T P

    1. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;

  3. Adejare, A

    1. Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;

  4. Aharony, D

    1. Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors.
      D Aharony, C A Catanese and R C Falcone
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 581-588;

  5. Alberts, A W

    1. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;

  6. Anders, M W

    1. Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells.
      L H Lash and M W Anders
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 531-537;

  7. Araki, S

    1. Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
      H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;

  8. Atchison, J A

    1. Colonic absorption of insulin: an in vitro and in vivo evaluation.
      J A Atchison, W E Grizzle and D J Pillion
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 567-572;

  9. Atchison, W D

    1. Block of 45Ca uptake into synaptosomes by methylmercury: Ca++- and Na+-dependence.
      T J Shafer and W D Atchison
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 696-702;

B

  1. Bannon, M J

    1. Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors.
      D M Haverstick, A Rubenstein and M J Bannon
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 858-862;

  2. Barry, W H

    1. Mechanism of protective effects of Ca++ channel blockers on energy deprivation contracture in cultured ventricular myocytes.
      O Kohmoto and W H Barry
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 871-878;

  3. Barzaghi, G

    1. Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture.
      G Barzaghi, H M Sarau and S Mong
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 559-566;

  4. Bedotto, J B

    1. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
      J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;

  5. Bend, J R

    1. Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver.
      G L Foureman, C Harris, F P Guengerich and J R Bend
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 492-497;

  6. Botella, J

    1. Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
      J Botella, I Duc, R Delansorne, J Paris and B Lahlou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;

  7. Bowyer, J F

    1. K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
      J F Bowyer and N Weiner
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 514-520;

  8. Brown, B S

    1. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
      B S Brown
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 552-558;

  9. Burch, R M

    1. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
      S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;

C

  1. Catanese, C A

    1. Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors.
      D Aharony, C A Catanese and R C Falcone
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 581-588;

  2. Chow, D D

    1. Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
      D D Chow, H E Essien, M M Padki and K J Hwang
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 506-513;

  3. Civiale, M A

    1. Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
      J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;

  4. Clow, D W

    1. Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen.
      D W Clow and K Jhamandas
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 722-728;

  5. Compton, D R

    1. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
      D R Compton and K M Johnson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 521-530;

  6. Coulson, R

    1. Xanthine effects on renal proximal tubular function and cyclic AMP metabolism.
      R Coulson and S J Scheinman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 589-595;

  7. Coyle, J T

    1. Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
      M Miyamoto, S Narumi, A Nagaoka and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 825-835;

  8. Cubeddu, L X

    1. Effects of low extracellular chloride on dopamine release and the dopamine transporter.
      P A Diliberto, R A Jeffs and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 644-653;

D

  1. Dandapani, B K

    1. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;

  2. Dehaas, C J

    1. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
      S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;

  3. Delansorne, R

    1. Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
      J Botella, I Duc, R Delansorne, J Paris and B Lahlou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;

  4. Diliberto, P A

    1. Effects of low extracellular chloride on dopamine release and the dopamine transporter.
      P A Diliberto, R A Jeffs and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 644-653;

  5. Docherty, J R

    1. Canine pulmonary artery contains a homogeneous population of alpha-1 adrenoceptors.
      J R Docherty and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 479-483;
    2. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
      J R Docherty
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 736-740;

  6. Duc, I

    1. Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
      J Botella, I Duc, R Delansorne, J Paris and B Lahlou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;

  7. Duchai, D M

    1. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;

E

  1. Easington, C

    1. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;

  2. Efange, S

    1. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;

  3. Eilam, Y

    1. Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes.
      H Hallaq, Y Hasin, R Fixler and Y Eilam
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 716-721;

  4. Epstein, S E

    1. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;

  5. Eschalier, A

    1. Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
      J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;

  6. Essien, H E

    1. Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
      D D Chow, H E Essien, M M Padki and K J Hwang
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 506-513;

F

  1. Falcone, R C

    1. Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors.
      D Aharony, C A Catanese and R C Falcone
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 581-588;

  2. Farmer, S G

    1. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
      S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;

  3. Fertel, R

    1. Pharmacological characterization of rat retinal dopamine receptors.
      Z X Qu, R Fertel, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 621-625;

  4. Feuerstein, G

    1. Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat.
      A L Sirén, P Paakkari, D S Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 596-604;

  5. Fialip, J

    1. Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
      J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;

  6. Fixler, R

    1. Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes.
      H Hallaq, Y Hasin, R Fixler and Y Eilam
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 716-721;

  7. Foureman, G L

    1. Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver.
      G L Foureman, C Harris, F P Guengerich and J R Bend
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 492-497;

  8. Fraser, C M

    1. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;

  9. Fujiwara, M

    1. Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;

  10. Furchgott, R F

    1. Interactions of light and sodium nitrite in producing relaxation of rabbit aorta.
      K Matsunaga and R F Furchgott
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 687-695;

G

  1. Gallager, D W

    1. Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. I. Modulation of gamma-aminobutyric acid sensitivity.
      M A Wilson and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 879-885;
    2. Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. II. Modulation of firing rate.
      M A Wilson and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 886-891;

  2. Garg, L C

    1. Cholinergic stimulation of phosphoinositide hydrolysis in renal medullary collecting duct cells.
      S McArdle and L C Garg
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 682-686;

  3. Gay, R G

    1. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
      J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;

  4. Germershausen, J I

    1. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;

  5. Gessner, G

    1. Studies on inhibition of angiotensin II receptors in rabbit adrenal and aorta.
      R G Pendleton, G Gessner and E Horner
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 637-643;

  6. Gillis, R A

    1. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
    2. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;

  7. Gnegy, M E

    1. Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.
      T Ryan-Jastrow and M E Gnegy
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 626-631;

  8. Goldman, S

    1. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
      J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;

  9. Goldstein, D S

    1. Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat.
      A L Sirén, P Paakkari, D S Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 596-604;

  10. Goldstein, S R

    1. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;

  11. Goto, K

    1. Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
      T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;

  12. Graham, S D

    1. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
      J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;

  13. Greene, R

    1. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;

  14. Grizzle, W E

    1. Colonic absorption of insulin: an in vitro and in vivo evaluation.
      J A Atchison, W E Grizzle and D J Pillion
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 567-572;

  15. Grover, G J

    1. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
      G J Grover and W A Schumacher
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 484-491;

  16. Guengerich, F P

    1. Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver.
      G L Foureman, C Harris, F P Guengerich and J R Bend
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 492-497;

  17. Guidotti, A

    1. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;

H

  1. Hadjiconstantinou, M

    1. Pharmacological characterization of rat retinal dopamine receptors.
      Z X Qu, R Fertel, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 621-625;

  2. Hallaq, H

    1. Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes.
      H Hallaq, Y Hasin, R Fixler and Y Eilam
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 716-721;

  3. Hamada, A

    1. Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;

  4. Hamosh, P

    1. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
    2. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;

  5. Harrington, B

    1. Evidence for muscarinic inhibitory neurotransmission in rodent small intestine.
      T V Nowak, B Harrington and J H Kalbfleisch
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 573-580;

  6. Harris, C

    1. Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver.
      G L Foureman, C Harris, F P Guengerich and J R Bend
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 492-497;

  7. Hasin, Y

    1. Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes.
      H Hallaq, Y Hasin, R Fixler and Y Eilam
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 716-721;

  8. Haverstick, D M

    1. Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors.
      D M Haverstick, A Rubenstein and M J Bannon
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 858-862;

  9. Hayashi, Y

    1. Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
      H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;

  10. Hefti, F

    1. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;

  11. Henry, P J

    1. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
      P J Henry, J D Horowitz and W J Louis
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 762-768;

  12. Hill, K J

    1. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;

  13. Hisa, H

    1. Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
      H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;

  14. Horner, E

    1. Studies on inhibition of angiotensin II receptors in rabbit adrenal and aorta.
      R G Pendleton, G Gessner and E Horner
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 637-643;

  15. Horowitz, J D

    1. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
      P J Henry, J D Horowitz and W J Louis
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 762-768;

  16. Hwang, K J

    1. Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
      D D Chow, H E Essien, M M Padki and K J Hwang
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 506-513;

I

  1. Inada, I

    1. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;

  2. Inatomi, N

    1. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;

  3. Ishikawa, T

    1. Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
      T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;

  4. Iwata, H

    1. Veratrine-induced decrease of (Na+ + K+)-adenosine triphosphatase activity in rat brain slices.
      T Matsuda and H Iwata
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 729-735;

J

  1. Jeffs, R A

    1. Effects of low extracellular chloride on dopamine release and the dopamine transporter.
      P A Diliberto, R A Jeffs and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 644-653;

  2. Jhamandas, K

    1. Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen.
      D W Clow and K Jhamandas
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 722-728;

  3. Johnson, K M

    1. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
      D R Compton and K M Johnson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 521-530;

K

  1. Kalbfleisch, J H

    1. Evidence for muscarinic inhibitory neurotransmission in rodent small intestine.
      T V Nowak, B Harrington and J H Kalbfleisch
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 573-580;

  2. Kellar, K J

    1. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;

  3. Kimes, A S

    1. Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal.
      A S Kimes and E D London
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 538-545;

  4. Kirby, J S

    1. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;

  5. Kohmoto, O

    1. Mechanism of protective effects of Ca++ channel blockers on energy deprivation contracture in cultured ventricular myocytes.
      O Kohmoto and W H Barry
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 871-878;

  6. Kornbrust, D J

    1. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;

  7. Kubo, K

    1. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
      H Nagaya, H Satoh, K Kubo and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 799-805;

  8. Kurahashi, K

    1. Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;

L

  1. Lahlou, B

    1. Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
      J Botella, I Duc, R Delansorne, J Paris and B Lahlou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;

  2. Lai, J

    1. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;

  3. Langer, S Z

    1. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
      H Schoemaker and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 710-715;

  4. Laplante, C

    1. Relaxant effect of N-formyl-methionyl-leucyl-phenylalanine on rabbit vascular strips.
      C Laplante, B Tremblay and F Marceau
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 774-780;

  5. Lash, L H

    1. Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells.
      L H Lash and M W Anders
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 531-537;

  6. Lichtensteiger, W

    1. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring.
      U Ribary and W Lichtensteiger
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 786-792;

  7. London, E D

    1. Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal.
      A S Kimes and E D London
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 538-545;

  8. Louis, W J

    1. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
      P J Henry, J D Horowitz and W J Louis
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 762-768;

M

  1. MacDonald, J S

    1. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;

  2. Makambila, M C

    1. Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
      J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;

  3. Maki, Y

    1. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
      H Nagaya, H Satoh, K Kubo and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 799-805;
    2. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;

  4. Malik, K U

    1. Uptake and hormonally induced hydrolysis of [3H]phosphatidyl choline in the isolated rabbit heart.
      M T Weis and K U Malik
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 614-620;

  5. Manabe, K

    1. Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;

  6. Marceau, F

    1. Relaxant effect of N-formyl-methionyl-leucyl-phenylalanine on rabbit vascular strips.
      C Laplante, B Tremblay and F Marceau
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 774-780;

  7. Markle, D R

    1. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;

  8. Marty, H

    1. Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
      J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;

  9. Matsuda, T

    1. Veratrine-induced decrease of (Na+ + K+)-adenosine triphosphatase activity in rat brain slices.
      T Matsuda and H Iwata
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 729-735;

  10. Matsunaga, K

    1. Interactions of light and sodium nitrite in producing relaxation of rabbit aorta.
      K Matsunaga and R F Furchgott
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 687-695;

  11. McArdle, S

    1. Cholinergic stimulation of phosphoinositide hydrolysis in renal medullary collecting duct cells.
      S McArdle and L C Garg
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 682-686;

  12. Mei, L

    1. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;

  13. Michel, P P

    1. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;

  14. Miller, D D

    1. Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;

  15. Miyamoto, M

    1. Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
      M Miyamoto, S Narumi, A Nagaoka and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 825-835;

  16. Miyauchi, T

    1. Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
      T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;

  17. Mong, S

    1. Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture.
      G Barzaghi, H M Sarau and S Mong
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 559-566;

  18. Morin, D

    1. Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats.
      S Urien, D Morin and J P Tillement
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 781-785;

  19. Morkin, E

    1. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
      J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;

  20. Morse, W H

    1. Environmental determinants of enhanced sensitivity to the behavioral effects of naltrexone.
      P H Warren and W H Morse
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 546-551;

  21. Moummi, C

    1. Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter.
      S Rattan and C Moummi
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 703-709;

N

  1. Nagaoka, A

    1. Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
      M Miyamoto, S Narumi, A Nagaoka and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 825-835;

  2. Nagaya, H

    1. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
      H Nagaya, H Satoh, K Kubo and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 799-805;
    2. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;

  3. Nakamura, N

    1. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;

  4. Namath, I J

    1. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;

  5. Narahashi, T

    1. Kinetics of chlorpromazine block of sodium channels in single guinea pig cardiac myocytes.
      N Ogata, M Nishimura and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 605-613;

  6. Narumi, S

    1. Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
      M Miyamoto, S Narumi, A Nagaoka and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 825-835;

  7. Neff, N H

    1. Pharmacological characterization of rat retinal dopamine receptors.
      Z X Qu, R Fertel, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 621-625;

  8. Nichols, A J

    1. Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;

  9. Niida, H

    1. Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection.
      K Takeuchi, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 836-841;

  10. Nishimura, M

    1. Kinetics of chlorpromazine block of sodium channels in single guinea pig cardiac myocytes.
      N Ogata, M Nishimura and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 605-613;

  11. Nishiwaki, H

    1. Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
      H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;

  12. Nohara, A

    1. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;

  13. Norman, W P

    1. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;

  14. Nowak, T V

    1. Evidence for muscarinic inhibitory neurotransmission in rodent small intestine.
      T V Nowak, B Harrington and J H Kalbfleisch
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 573-580;

O

  1. Ogata, N

    1. Kinetics of chlorpromazine block of sodium channels in single guinea pig cardiac myocytes.
      N Ogata, M Nishimura and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 605-613;

  2. Okabe, S

    1. Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
      H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;
    2. Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection.
      K Takeuchi, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 836-841;

  3. Okada, M

    1. Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
      H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;
    2. Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection.
      K Takeuchi, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 836-841;

P

  1. Paakkari, P

    1. Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat.
      A L Sirén, P Paakkari, D S Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 596-604;

  2. Padki, M M

    1. Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
      D D Chow, H E Essien, M M Padki and K J Hwang
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 506-513;

  3. Paris, J

    1. Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
      J Botella, I Duc, R Delansorne, J Paris and B Lahlou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;

  4. Patil, P N

    1. Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;

  5. Patterson, R E

    1. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;

  6. Pendleton, R G

    1. Studies on inhibition of angiotensin II receptors in rabbit adrenal and aorta.
      R G Pendleton, G Gessner and E Horner
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 637-643;

  7. Peter, C P

    1. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;

  8. Pillion, D J

    1. Colonic absorption of insulin: an in vitro and in vivo evaluation.
      J A Atchison, W E Grizzle and D J Pillion
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 567-572;

  9. Plante, G E

    1. Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
      G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;

  10. Pressman, B C

    1. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;

  11. Prévost, C

    1. Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
      G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;

  12. Prost, J F

    1. Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
      G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;

Q

  1. Qu, Z X

    1. Pharmacological characterization of rat retinal dopamine receptors.
      Z X Qu, R Fertel, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 621-625;

  2. Quest, J A

    1. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
    2. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;

R

  1. Rattan, S

    1. Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter.
      S Rattan and C Moummi
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 703-709;

  2. Ribary, U

    1. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring.
      U Ribary and W Lichtensteiger
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 786-792;

  3. Ro, Y M

    1. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;

  4. Rochat, C

    1. Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
      G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;

  5. Roeske, W R

    1. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;

  6. Rubenstein, A

    1. Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors.
      D M Haverstick, A Rubenstein and M J Bannon
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 858-862;

  7. Ruffolo, R R

    1. Canine pulmonary artery contains a homogeneous population of alpha-1 adrenoceptors.
      J R Docherty and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 479-483;
    2. Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;

  8. Ryan-Jastrow, T

    1. Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.
      T Ryan-Jastrow and M E Gnegy
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 626-631;

S

  1. Saito, A

    1. Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
      T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;

  2. Sanchez-Ramos, J

    1. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;

  3. Sarau, H M

    1. Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture.
      G Barzaghi, H M Sarau and S Mong
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 559-566;

  4. Satoh, H

    1. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
      H Nagaya, H Satoh, K Kubo and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 799-805;
    2. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;

  5. Satoh, S

    1. Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
      H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;

  6. Scheinman, S J

    1. Xanthine effects on renal proximal tubular function and cyclic AMP metabolism.
      R Coulson and S J Scheinman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 589-595;

  7. Schoemaker, H

    1. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
      H Schoemaker and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 710-715;

  8. Schumacher, W A

    1. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
      G J Grover and W A Schumacher
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 484-491;

  9. Shafer, T J

    1. Block of 45Ca uptake into synaptosomes by methylmercury: Ca++- and Na+-dependence.
      T J Shafer and W D Atchison
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 696-702;

  10. Shirahase, H

    1. Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;

  11. Sirén, A L

    1. Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat.
      A L Sirén, P Paakkari, D S Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 596-604;

  12. Sirois, P

    1. Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
      G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;

  13. Speir, E

    1. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;

  14. Steadman, K

    1. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;

  15. Steranka, L R

    1. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
      S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;

  16. Stubbs, R J

    1. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;

  17. Sugishita, Y

    1. Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
      T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;

T

  1. Takeuchi, K

    1. Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
      H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;
    2. Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection.
      K Takeuchi, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 836-841;

  2. Tanaka, H

    1. Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
      H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;

  3. Taveira da Silva, A M

    1. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;

  4. Tillement, J P

    1. Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats.
      S Urien, D Morin and J P Tillement
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 781-785;

  5. Togo, J

    1. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
      S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;

  6. Tomura, Y

    1. Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
      H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;

  7. Tremblay, B

    1. Relaxant effect of N-formyl-methionyl-leucyl-phenylalanine on rabbit vascular strips.
      C Laplante, B Tremblay and F Marceau
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 774-780;

U

  1. Urien, S

    1. Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats.
      S Urien, D Morin and J P Tillement
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 781-785;

  2. Usui, H

    1. Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;

V

  1. Venter, J C

    1. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;

W

  1. Warren, P H

    1. Environmental determinants of enhanced sensitivity to the behavioral effects of naltrexone.
      P H Warren and W H Morse
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 546-551;

  2. Weiner, N

    1. K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
      J F Bowyer and N Weiner
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 514-520;

  3. Weis, M T

    1. Uptake and hormonally induced hydrolysis of [3H]phosphatidyl choline in the isolated rabbit heart.
      M T Weis and K U Malik
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 614-620;

  4. Wilson, M A

    1. Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. I. Modulation of gamma-aminobutyric acid sensitivity.
      M A Wilson and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 879-885;
    2. Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. II. Modulation of firing rate.
      M A Wilson and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 886-891;

Y

  1. Yamamura, H I

    1. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;
Back to top

In this issue